Tumor angiogenesis in predicting the survival of patients with stage I lung cancer

被引:15
|
作者
Medetoglu, Baris [1 ]
Gunluoglu, Mehmet Zeki [1 ]
Demir, Adalet [1 ]
Melek, Huseyin [1 ]
Buyukpinarbasili, Nur [2 ]
Fener, Neslihan [2 ]
Dincer, Seyyit Ibrahim [1 ]
机构
[1] Yedikule Teaching Hosp Chest Dis & Thorac Surg, Dept Thorac Surg, Istanbul, Turkey
[2] Yedikule Teaching Hosp Chest Dis & Thorac Surg, Dept Pathol, Istanbul, Turkey
来源
关键词
ENDOTHELIAL GROWTH-FACTOR; PROGNOSTIC IMPACT; CD105; EXPRESSION; CARCINOMA; VEGF; METASTASIS; DENSITY; CD31;
D O I
10.1016/j.jtcvs.2010.07.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The effects of angiogenesis on survival were assessed by measuring the tumor microvessel density and vascular endothelial growth factor expression in patients with resected stage I non-small cell lung carcinoma. Methods: The study population included 141 patients who underwent complete resection for stage pT1 and T2 N0 M0 tumors between 1999 and 2007. Lobectomy and pneumonectomy were performed in 131 and 10 patients, respectively. Tumor specimens were analyzed immunohistochemically for staining with anti-CD105 antibody to determine tumor microvessel density and anti-vascular endothelial growth factor antibody to determine the vascular endothelial growth factor expression level. Univariate and multivariate analyses were performed for factors influencing patients' survival. Results: The overall 5-year survival was calculated as 68%, with rates of 76.9% for patients with T1 disease and 66.2% for patients with T2 disease (P = .4). The vascular endothelial growth factor expression rate was 94.3% for patients with stage I non-small cell lung carcinoma. Vascular endothelial growth factor expression did not influence survival (P = .9). The median microvessel density of the tumors measured based on the level of CD105 expression was 19.8. The effect of microvessel density on survival was significant (P = .02). The 5-year survivals of patients with tumors with 20 or more microvessels and less than 20 microvessels were 76.8% and 56.1%, respectively; this difference was highly significant (P = .004). The microvessel density was determined as an independent factor influencing survival on multivariate analysis (P = .03). Conclusions: The level of vascular endothelial growth factor expression in tumors was not a successful predictor of survival in patients with resected stage I non-small cell lung carcinoma. A high microvessel density based on CD105 is a strong predictor of prognosis in these patients. (J Thorac Cardiovasc Surg 2010;140:996-1000)
引用
收藏
页码:996 / 1000
页数:5
相关论文
共 50 条
  • [1] Description and Survival of Stage I and II Lung Cancer Patients
    Perez-Martinez, Olaia
    Vidal-Garcia, Iria
    Montero-Martinez, Carmen
    Provencio, Mariano
    Ruano-Ravina, Alberto
    ARCHIVOS DE BRONCONEUMOLOGIA, 2018, 54 (08): : 420 - 426
  • [2] Tumor angiogenesis and recurrence in stage I non-small cell lung cancer
    Ohta, Y
    Tomita, Y
    Oda, M
    Watanabe, S
    Murakami, S
    Watanabe, Y
    ANNALS OF THORACIC SURGERY, 1999, 68 (03): : 1034 - 1038
  • [3] Development and validation of nomogram for predicting survival of elderly patients with stage I small-cell lung cancer
    Yang, Yaji
    Sun, Shusen
    Wang, Yuwei
    Xiong, Feng
    Xiao, Yin
    Huang, Jing
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2021, 21 (05) : 632 - 641
  • [4] Effects of pneumonectomy on survival of patients with stage I lung cancer - Reply
    Alexiou, C
    Beggs, D
    Doukas, G
    Kotidis, K
    Morgan, E
    Rocco, G
    ANNALS OF THORACIC SURGERY, 2005, 79 (01): : 384 - 385
  • [5] Survival of patients with stage I lung cancer detected on CT screening
    Henschke, Claudia I.
    Yankelevitz, David F.
    Libby, Daniel M.
    Pasmantier, Mark W.
    Smith, James P.
    Miettinen, Olli S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (17): : 1763 - 1771
  • [6] Predicting survival outcome for stage Ill lung cancer
    Oberije, C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S47 - S47
  • [7] Tumor angiogenesis as a major prognostic factor in stage I lung adenocarcinoma
    Kawaguchi, T
    Yamamoto, S
    Kudoh, S
    Goto, K
    Wakasa, K
    Sakurai, M
    ANTICANCER RESEARCH, 1997, 17 (5B) : 3743 - 3746
  • [8] Effects of Tumor Stroma and Inflammation on Survival of Stage I-IIp Lung Cancer
    Millares, L.
    Alcaraz, J.
    Martinez, A.
    Benchea, I.
    Carrasco, J.
    Sanchez De Cos, J.
    Gonzalez-Castro, M. A.
    Blanco, A.
    Sanchez-Gil, R.
    Serra, M.
    Rami-Porta, R.
    Sauleda, J.
    Fernandez, E.
    Melchor, R.
    Seijo, L.
    De Esteban Julvez, L.
    Barreiro, E.
    Monso, E.
    Ciberes-Rticc-Separ-Plataforma, C. G. I. L. C.
    Pulmonar, Biobanco
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1983 - S1984
  • [9] Survival in resected stage I lung cancer with residual tumor at the bronchial resection margin
    Snijder, RJ
    de la Rivière, AB
    Elbers, HJJ
    van den Bosch, JMM
    ANNALS OF THORACIC SURGERY, 1998, 65 (01): : 212 - 216
  • [10] Effects of tumor stroma and inflammation on survival of stage I-IIp lung cancer
    Costas, Laura Millares
    Alcaraz, Jordi
    Benchea, Iuliana
    Carrasco, Josep Lluis
    de Cos, Julio Sanchez
    Castro, Maria Angeles Gonzalez
    Blanco, Ana
    Gil, Rosa Sanchez
    Serra, Mireia
    Rami, Ramon
    Sauleda, Jaume
    Fernandez, Esther
    Melchor, Rosario
    Seijo, Luis
    Julvez, Leonardo de Esteban
    Barreiro, Esther
    Monso, Eduard
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50